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Background: The prevalence of type 2 diabetes has increased dramatically in the last decade, and is continuing
to rise. It is a chronic condition, often related to obesity, diet and sedentary lifestyles, and can lead to significant
health complications, disability and early death. Diabetes is commonly associated with depression, which can
impact significantly on a person’s ability to manage their illness and, consequently, on disease outcomes. Disease
self-management is fundamental in diabetes and requires support from multiple health professionals and the active
participation of the person, including in maintaining a healthy lifestyle. The Whole Person Model was developed in
order to integrate emotional and behavioural aspects into a self-management program for people with type
2 diabetes. Here we describe a study designed to test the efficacy of the Whole Person Model of disease
self-management in type 2 diabetes.
Methods/Design: In a parallel-group randomised trial, 180 people with type 2 diabetes of between 2–10 years
duration will be recruited via invitation through the Australian National Diabetes Services Scheme. Participants will
undergo baseline assessment, followed by randomisation to either intervention or control condition. Control
participants will receive fact sheets containing key information about diabetes self-management. The intervention
group will receive the INSPIRED (Individual Support & Resources for Diabetes) Manual and be assigned a Health
Coach. The INSPIRED Manual consists of six modules that provide key information about diabetes and disease
management using the Whole Person Model. Engagement is facilitated by interactive tasks and contact with a
Health Coach over seven weeks – an introductory face-to-face session, and six subsequent contacts by phone
following each module. Follow-up assessments occur at 13 weeks (post-intervention) and 26 weeks. Primary
outcomes include blood glucose management (HbA1c), weight and mood. Secondary outcomes include level of
exercise, confidence to manage diabetes, and psychosocial well-being.
Discussion: The Whole Person Model is designed to enable health professionals to address mood disturbance
without pathologizing any disorders and, in the context of the chronic illness, empowering behavior change and
self-management. If proven effective, this model will strengthen capacity of the healthcare workforce to foster and
support effective diabetes self-management.
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Diabetes is a chronic disease
Diabetes mellitus is a metabolic disease with serious
implications for both the individual and society. There
are currently about 220 million people with diabetes
worldwide [1], and the number is projected to exceed
366 million by the year 2030 [2]. Type 2 diabetes ac-
counts for 90–95 percent of cases of diabetes. Although,
the specific aetiologies of type 2 diabetes are not known,
insulin resistance – that is, where insulin is ineffective in
the peripheral tissues – seems to be the major factor, in
contrast to absolute insulin deficiency seen in type 1
diabetes [3]. Apart from genetic disposition, the main
factors associated with risk of type 2 diabetes appear to
be diet, inactivity and body weight – essentially lifestyle
factors. Obesity, itself, is associated with insulin resist-
ance. And while the prevalence of obesity is increasing
in our communities, there are indications also that type
2 diabetes is increasingly developing earlier in life [4,5].
Type 2 diabetes develops insidiously and often goes un-
diagnosed for many years because of lack of symptoms
in the early stages. It is estimated that up to 6.3 million
Americans have undiagnosed diabetes [6].
Diabetes, if undetected or poorly controlled, can result
in serious long-term health problems. These include
diabetic neuropathy, retinopathy, peripheral vascular
disease, renal failure, heart disease and stroke [1]. World-
wide, 2.9 million deaths per year are directly attributable
to diabetes, equivalent to 5.2% of world all-cause mortality
[7]. Excess mortality attributable to diabetes was over 8%
in the U.S.A, Canada and Middle East [7]. Type 2 diabetes
is projected to be the leading specific cause of disease
burden in Australia for males and second for females by
the year 2023 [8].
Depression and diabetes
Depression is common in people with type 2 diabetes with
reported prevalence rates between 9% and 27% [9-11]. This
level is about twice as high as that found in the non-
diabetic population [12]. The evidence suggests that
depression is an independent risk factor for diabetes, with
depressed adults having a 37% increased risk of developing
type 2 diabetes, compared with those who are not de-
pressed [13]. Clearly there are behavioral factors to partly
explain this - for example, depressed people are more likely
to be overweight [14], and to exercise less [15]. In addition
there are biological factors at play. Potential pathophysio-
logical mechanisms include effects of stress and depression
acting via cortisol to stimulate glucose production, increase
lipolysis and circulating free fatty acids, decrease insulin
secretion, and decrease sensitivity to insulin [16]. Further-
more, depression is associated with increased activity of
the pro-inflammatory pathway, and inflammation, also, is
associated with insulin resistance [17].These same mechanisms operate in established dia-
betes. And in addition to the above, depression interferes
with disease management. Depression, and its accom-
panying feelings of negativity, pessimism, and hopeless-
ness, impairs attention to treatment, diet, exercise etc.
[18]. It is very easy for helplessness to set in. Even low
levels of depressive symptoms have been shown to be
associated with non-adherence to diabetes self-care [19].
Depressive symptoms markedly impair quality of life in
both generic and diabetes-specific domains [20] and is
associated with higher blood glucose levels [21,22],
greater insulin resistance [23], and impaired metabolic
control [24]. This, in turn results in more diabetes-
related medical complications and higher mortality [25].
Finally, we can note that the presence of depression is
associated with an increased cost of diabetes care by
50% [26].
Chronic disease self-management and the Whole Person
Model
The treatment of type 2 diabetes includes weight manage-
ment, physical activity and dietary modification, together
with glucose-lowering medication. To minimize the risk
of complications, and to maximize health, regular medical
follow-up is required to monitor disease status. This in-
volves regular physical examination (including of feet and
eyes), and monitoring of HbA1c and other metabolic risk
factors [3]. People with diabetes require a range of ser-
vices, including primary care physicians, endocrinologists,
diabetes educators, dieticians, optometrists and podia-
trists; and depending on need, this might include psychia-
trists, psychologists, physiotherapists, ophthalmologists,
nephrologists, cardiologists and social workers. This can
become a full-time occupation for those affected by com-
plicated diabetes and, increasingly, it is recognized that a
person with diabetes not only has to manage their illness
and comorbidities, emotional distress and lifestyle factors,
but also to navigate a complicated health care system,
which is not always patient-focused.
Chronic diabetes self-management interventions, inclu-
ding education programs and individual coaching support
have been shown to have moderate effectiveness, and vary
in their level of intensity [27,28]. Specifically those inter-
ventions which incorporate behavioural strategies, and/or
ongoing coaching support with a health professional have
demonstrated sustained improved outcomes [27,28].
The Diabetes Attitudes Wishes and Needs (DAWN)
study [29], a large and ongoing international prospective
study of people with diabetes, found the following
actions to be important in improving health and quality-
of-life for people with diabetes:
 Enhance communications between people with
diabetes and healthcare providers
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 Promote active self-management
 Overcome emotional barriers to effective therapy
 Enable better psychological care for people with
diabetes.
The Whole Person Model was developed by Baird and
Clarke [30,31], within a framework of disease self-
management, as a mechanism to integrate all these
actions. It essentially uses a cognitive behavioural frame,
although, in traditional cognitive behavioural therapy
(CBT), less emphasis is usually given to the physical
components. In the Whole Person Model, it is under-
stood that how individuals feel (sad, anxious, angry or
determined) will affect how they think and behave,
including with respect to health related behaviours.
These in turn affect health, through inadequate adher-
ence to treatment plans and a healthy lifestyle.
The Whole Person Model approach to self-management
aims to provide a health promotion self-management
program to enable consumers and health professionals to
work together and engage in all aspects of their diabetes
management. In addition to providing information about
the condition and management strategies, it focuses on
enabling health promotion strategies to provide the “how”
to putting these into place. The program anticipates
potential barriers, supports strategies to address these bar-
riers and looks at the emotional impact of the condition.
It is designed to provide a useful vehicle for addressing
diabetes management from the consumer’s perspective.
Although not attempting to specifically diagnose or treat
depression or anxiety disorders, it does explore emotional
responses in the context of diabetes and its management –
‘diabetes-specific distress’ [32]. In this way, the worries,
frustrations and helplessness that so often arise with
diabetes management are targeted, and support is provided
to promote active participation and optimal self-manage-
ment. In this context, we aim to apply the Whole Person
Model in a health promotion, self-management program
to improve health related behaviours, health outcomes
and mood for those with diabetes, and here, in this manu-
script, we describe the study protocol for the INSPIRED
(Individual Support & Resources for Diabetes) project.
Methods/Design
Study aims and hypotheses
The study aims to evaluate, through a parallel-group ran-
domised controlled trial, the efficacy of a type 2 diabetes
self-management program, including a resource consisting
of the INSPIRED Manual facilitated by seven weekly
sessions with a Health Coach. The supported education
intervention promotes wellness by facilitating self-man-
agement and is designed to enable those individuals with
depression to gain understanding and acknowledgementof their emotional struggles. The Health Coaches are
qualified Diabetes Educators, trained in the Whole Person
Model. It is hypothesized that, compared to those in the
control group, the intervention group will demonstrate
improvement in the three primary outcomes of blood glu-
cose management (HbA1c), weight and mood. We also
hypothesize that improvements will occur in exercise
level, ability to manage diabetes and psychosocial well-
being.
Participant recruitment
Participants with type 2 diabetes will be recruited, via invi-
tation, through the National Diabetes Services Scheme
which is a large support scheme for people with diabetes.
Approximately 1,098,780 Australians with diabetes are
registered with the National Diabetes Services Scheme, of
which 86% have been diagnosed with type 2 diabetes. Ap-
proximately 6% include those who reside in Victoria, meet
inclusion criteria and have nominated to receive infor-
mation about research opportunities related to diabetes.
These individuals will be invited to participate in the pro-
ject. This method of recruitment will be supplemented by
advertisement online via the Diabetes Australia, Victoria
website. People will indicate their interest by contacting
the research team by telephone. Inclusion criteria are: 1)
having had diagnosed type 2 diabetes for between 2 and
10 years, 2) aged 18 years or over, 3) a Body Mass Index
(BMI) between 20 and 40, 4) not currently on insulin, 5)
sufficient speech and reading fluency in English to read
and understand the INSPIRED Manual (determined using
the Single Item Literacy Screener [33]), and 6) able to give
informed consent. People will be excluded if they have sig-
nificant cognitive impairment or other infirmity which
would obviously preclude their participation. If eligible
and willing to participate, potential participants will be
met by a research assistant, when consent forms will be
signed and baseline measures taken.
Randomisation
The randomisation process will be conducted by an
independent statistician. Stata Version 12 [34] statistical
package will be used for the random allocation of subjects
to either the intervention or the control group. To ensure
equal allocation (1:1), block randomisation method will be
used. A pre-defined randomised list containing ID num-
bers and their respective treatment allocation will be
provided to the Project Coordinator (DP) who will not be
involved in taking measurements, data management or
statistical analyses. ID numbers will be assigned to partici-
pants in consecutive order to avoid selection bias.
Intervention
Participants randomised to the control group will receive
standard information sheets containing key information
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mation sheets primarily include those which are part of an
information series from State/Territory organisation of
Diabetes Australia. These will be posted to participants
from the study headquarters.
Participants randomised to active treatment will be
assigned a trained Health Coach, and will be provided
with the INSPIRED Manual during an initial face-to-face
meeting with their Health Coach. The INSPIRED Manual
provides key information about diabetes and management
of diabetes, guidance about diet and exercise, and skills
training. Issues of emotions (determined, sad, anxious,
angry) are acknowledged and addressed in the context of
their disease self-management and their relationships with
family and health professionals. This is all designed to
facilitate self-management. The specific topics covered have
been developed through consumer participation and con-
sultation with key clinical experts and stakeholders (see
Table 1 for further intervention details). Using the Whole
Person Model, the INSPIRED Manual in combination with
the support and guidance of a Health Coach, aims to
encourage the reader to consider how their body, their
thoughts and feelings, and their health behaviors are all
interdependent. This combination aims to help people to
be aware of their thinking and learn strategies to improve
their mood and make lifestyle changes. An accompanying
INSPIRED Journal will also be provided to participants,
which assists them to keep track of their medical appoint-
ments, health goals and to improve communication with
their health professionals.
Participants will receive seven sessions with a Health
Coach over a 7 week period as follows:
 One face-to-face session, involving an orientation to
the INSPIRED Manual and the Whole Person
Model, conducted at the study headquarters.
 Six weekly phone coaching sessions. During these
calls the Health Coach will support the participant
working through the INSPIRED Manual, answering
questions, helping with goal-setting, and discussing
the homework exercises.
Outcomes assessments
Measures will be assessed at baseline, 13 weeks and 26 weeks.
Primary outcome measures will be blood glucose
management (HbA1c), weight and mood. Secondary out-
come measures include level of exercise, confidence to
manage diabetes (self-report) and psychosocial well-being
(self-report) using validated tools. The research assistant
collecting the data will be uninformed of group allocation.
Measures
Details about participants, including age, sex, height,
education level, employment status and current medicationswill be obtained at baseline. Weight, waist girth and HbA1c,
will be measured at each time point (baseline and 13 and
26 weeks). Participants will undergo a blood test at each
time point, at Monash Medical Centre, Melbourne,
Australia. Normal HbA1c will be assayed on site at Southern
Cross Pathology, Monash Medical Centre, Melbourne,
Victoria, Australia. Assay instrument is Adams A1C HA-
8160 automatic Glycohaemoglobin analyzer. The method
is based upon the principles of high performance liquid
chromatography (HPLC).
The following validated self-report measures will also
be measured at each time point:
 Mood: The Depression, Anxiety and Stress Scale
(DASS) [35] is a 21-item scale that assesses three
negative emotional states: Depression, Anxiety and
Stress and is shown to have excellent psychometric
properties in adults [36].
 Experience of demoralisation: The Demoralisation
Scale [37] is a 24-item self-report scale with a
Cronbach’s alpha of 0.96, measuring depression
commonly seen in the physically ill – particularly
aspects of helplessness, hopelessness and loss of
meaning [37,38].
 Social support: The Multidimensional Scale of
Perceived Social Support Scale [39] is a 12-item scale
that measures perceived social support from family,
friends and significant others. This scale has proven
to be psychometrically sound in diverse samples
with strong test-retest reliability over a 2–3 month
interval (r = 0.72 to 0.85), and internal consistencies
of the total scale and sub-scales which are high
(Cronbach’s Alpha = 0.79 to 0.98) [39].
 Self-efficacy: Diabetes Empowerment Scale – Short
Form [40] is an 8-item self-report scale which is a
valid and reliable measure of perceived ability to
manage the psychological and social demands and
challenges associated with diabetes [40]. Higher
mean scores indicate greater level of confidence
managing one’s diabetes.
 Level of exercise: Participants will be asked to record
the total number of steps taken over any three days
within a seven day period. This will be measured
using a Be Active pedometer (Multifunction
Pedometer, WWA2026, Reed Switch Technology)
provided to them at the initial assessment. A three
day period was noted by Tudor-Locke et al. [41] as a
sufficient number of days to reliably measure physical
activity in adults.
 Quality of Life: The EuroQol (EQ-5 D) [42] is a
brief self-report measure of subjective quality of life.
This measure has been used in intervention studies
with depressed patients [43], and will allow the
calculation of quality-adjusted life years (QALY).










▪ Diabetes and driving
▪ Diabetes and alcohol/smoking
▪ Importance of self-management
Healthy eating Providing weekly support and education
about:
▪ Barriers to healthy eating
▪ Tips for healthy eating and snack choices
▪ Managing food cravings
▪ Home-grown experiments
▪ Emotions and eating
▪ Eating out
▪ Reading food labels
Becoming more
physically active
Providing weekly support and education
about:
▪ Attitudes about different types of
physical activity
▪ Benefits of physical activity
▪ Keeping track of your steps using
your pedometer
▪ How to be more physically active
▪ Physical activity and blood glucose
levels
Weight management Providing weekly support and education
about:
▪ Your Body Mass Index
▪ Losing weight the healthy way
▪ Weight loss and maintenance tips
▪ Healthy eating tips for weight loss
Monitoring your diabetes Providing weekly support and education
about:
▪ Keeping track of your diabetes using
your Journal
▪ Paying attention to your blood glucose
levels
Maintaining contact with
your doctor and other
health professionals
Providing weekly support and education
about:
▪ Choosing a doctor
▪ The importance of keeping in regular
contact with your doctor
▪ How to get the most from your doctor’s
visit




Providing weekly support and education
about:










▪ Reducing feelings of tension and
worry – problem solving
▪ Tips to reduce the impact of anger
The Whole Person
Model
Providing weekly support and education
about:
▪ The Whole Person Model
▪ Considering your body, feelings and
thoughts when making an Action Plan
▪ Examining your thinking and talking
back unhelpful thoughts
Toolbox for a healthy life Providing weekly support and education
about:
▪ What to put in your tool box for a
healthy life?
- Things I am going to try
- Things I am going to think about
- Other ideas
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Participant/Therapist Version (WAI) is a valid meas-
ure of treatment alliance [44] and will be completed by
participants in the intervention group following phone
sessions at 1, 3 and 6 weeks, and by the Health Coach at
these times.
Study integrity and quality assurance
Ethical approval for this study has been obtained from
both the Monash Health Human Research Ethics
Committee and the Monash University Human Research
Ethics Committee. The study design will be guided by
the CONSORT statement [45,46]. Each participant will
be screened for eligibility and enrolled if eligible and
consenting. To ensure consistency and best practice,
participant’s height, weight and girth measurements are
taken as per recommendations outlined by the World
Health Organization [47]. The randomisation process
will be conducted by an independent statistician. Assess-
ments at baseline, 13 and 26 weeks will be carried out
by a research assistant who will be uninformed of group
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the intervention are qualified Diabetes Educators and
trained in the Whole Person Model. As well as the initial
training, reflective practice support and supervision will
be provided to the Health Coaches. The Project Coord-
inator will monitor the delivery of the intervention via
recordings of phone sessions for the first participant of
each Health Coach and random subsequent coaching
sessions. Constructive feedback will be provided where
necessary, and a fidelity checklist completed. Quality of
health coaching will also be assured using measures of
treatment alliance. No significant risks to participants
are anticipated.
Sample size justification
Using information from comparative studies, 150 par-
ticipants are required to detect a between group dif-
ference of 0.7% (SD ± 1.5) in HbA1c, with 80% power
and at an alpha level of 0.05 [48]. Similarly, 150 par-
ticipants are needed to detect a between group differ-
ence in weight of 4.4 kg (SD ± 9.6) with 80% power
and at an alpha level of 0.05 [49]. Based on a com-
parative sample using the DASS [50], at least 116
participants are required to detect a hypothesised
reduction of 25% in DASS score (20 to 15, SD ± 9.6).
On the basis of this analysis, and assuming a dropout
rate of 20% based on prior experience, we estimate
that a recruited sample of 180 will be required and
be sufficient to give the requisite power.
Statistical analyses
Continuous variables will be assessed for their distri-
bution and outliers prior to analyses. Variables will be
transformed if distributional/linearity assumptions are
violated. We will compare group characteristics using
student t-test for continuous variables, Chi-square
(χ2) or Fisher’s exact test for categorical variables. We
will conduct univariable and multivariable linear re-
gression analyses adjusting for appropriate covariates
and test for interactions. For dichotomous outcomes,
logistic regression analyses will be implemented. All
analyses are to be conducted on an intention-to-treat
basis (ITT). However, we may conduct a sensitivity
analysis using the imputation method chained equa-
tions (ICE) if we find a disproportionate level of miss-
ing values that are assessed as missing at random
(MAR). Stata Version 12 [34] will be used for all stat-
istical analyses.
Discussion
This study will examine the efficacy of a novel model of
disease self-management. The novelty is the Whole Person
Model, which integrates usual self-management principles
with attention to the feelings of the person in a way thatdoes not pathologize depression or anxiety, but seeks
to understand it in the context of a person struggling,
perhaps, with their disease and management of it. In
this program we include access to a trained Health
Coach as we have concluded from our experience
that this offers necessary support to the person whilst
they take in new information, and attempt significant
and sometimes difficult, behaviour change. We know
that both the integrated model and the support of the
Health Coach are critical factors in this change. Such
knowledge has informed the design of the study that
compares the active intervention with a fairly passive
approach of delivery of information in the control group.
If shown to be effective, this model will be easily im-
plementable in clinical practice. Diabetes Educators are
commonly employed around the world, and the Whole
Person Model is operationalized in the INSPIRED
Manual. Consequently, the model could easily be widely
implemented in a way that would have a huge effect on
population health.
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